3-Methoxy-N-[3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl]-benzamide

ID: ALA1084617

Cas Number: 887936-68-7

PubChem CID: 11604525

Product Number: T726144, Order Now?

Max Phase: Phase

Molecular Formula: C24H28N4O4

Molecular Weight: 436.51

Molecule Type: Small molecule

Associated Items:

This product is currently unavailable

Names and Identifiers

Synonyms: Apd791 | Temanogrel | APD-791 | APD791 | TEMANOGREL|887936-68-7|APD791|Temanogrel [USAN:INN]|UNII-F42Z27575A|APD 791|APD-791|Benzamide, 3-methoxy-N-[3-(1-methyl-1H-pyrazol-5-yl)-4-[2-(4-morpholinyl)ethoxy]phenyl]-|F42Z27575A|CHEMBL1084617|3-Methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-(morpholin-4- yl)ethoxy)phenyl)benzamide|3-Methoxy-N-(3-(2-methyl-2H-pyrazol-3-yl)-4-(2-morpholin-4-yl-ethoxy)-phenyl)- benzamide|3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide|BenShow More

Synonyms from Alternative Forms(3): Temanogrel hcl | APD791 | Temanogrel hydrochloride

Canonical SMILES:  COc1cccc(C(=O)Nc2ccc(OCCN3CCOCC3)c(-c3ccnn3C)c2)c1

Standard InChI:  InChI=1S/C24H28N4O4/c1-27-22(8-9-25-27)21-17-19(26-24(29)18-4-3-5-20(16-18)30-2)6-7-23(21)32-15-12-28-10-13-31-14-11-28/h3-9,16-17H,10-15H2,1-2H3,(H,26,29)

Standard InChI Key:  ZEOQUKRCASTCFR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
  -11.2173    0.3992    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -12.0019    0.1443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.3997    0.4414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.6150    0.6963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.1735   -0.6627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.9581   -0.9177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.5712   -0.3656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.1296   -1.7246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -12.5165   -2.2767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -13.9142   -1.9796    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -14.0858   -2.7865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.8704   -3.0415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.4727   -3.3386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -13.6442   -4.1455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.4288   -4.4005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -15.0419   -3.8484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -15.8265   -4.1034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -17.1614   -4.1034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -16.4940   -3.6185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -16.0815   -4.8880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.9065   -4.8880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.4940   -2.7935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -14.6004   -5.2075    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -15.3850   -5.4624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -15.5565   -6.2694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.3411   -6.5243    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  -17.7388   -6.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.9542   -5.9723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -16.5127   -7.3313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -17.2973   -7.5862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  -17.9104   -7.0342    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  -11.0458    1.2062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  4  2  2  0
  2  5  1  0
  3  4  1  0
  3  7  2  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 12 11  2  0
 11 13  1  0
 12 16  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 19 17  1  0
 17 20  2  0
 18 19  1  0
 18 21  2  0
 20 21  1  0
 19 22  1  0
 15 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 28 26  1  0
 26 29  1  0
 27 28  1  0
 27 31  1  0
 29 30  1  0
 30 31  1  0
  1 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA1084617

    Temanogrel
  2. Alternative Forms:

Associated Targets(Human)

HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 436.51Molecular Weight (Monoisotopic): 436.2111AlogP: 3.06#Rotatable Bonds: 8
Polar Surface Area: 77.85Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.76CX LogP: 2.55CX LogD: 2.46
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.58Np Likeness Score: -1.86

References

1. Xiong Y, Teegarden BR, Choi JS, Strah-Pleynet S, Decaire M, Jayakumar H, Dosa PI, Casper MD, Pham L, Feichtinger K, Ullman B, Adams J, Yuskin D, Frazer J, Morgan M, Sadeque A, Chen W, Webb RR, Connolly DT, Semple G, Al-Shamma H..  (2010)  Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis.,  53  (11): [PMID:20455563] [10.1021/jm100044a]
2. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, 
3. Unpublished dataset,